Accessibility Menu
Cardio Diagnostics Stock Quote

Cardio Diagnostics (NASDAQ: CDIO)

$2.79
(-12.3%)
-0.39
Price as of December 31, 2025, 2:12 p.m. ET

KEY DATA POINTS

Current Price
$2.79
Daily Change
(-12.3%) $0.39
Day's Range
$2.70 - $3.07
Previous Close
$3.18
Open
$3.07
Beta
0.99
Volume
46,791
Average Volume
35,575
Market Cap
$5.8M
Market Cap / Employee
$3.18M
52wk Range
$2.42 - $30.60
Revenue
N/A
Gross Margin
-23.61%
Dividend Yield
N/A
EPS
-$3.90
CAPs Rating
N/A
Industry
Biotechnology

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Cardio Diagnostics Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
CDIO-87.14%N/AN/A-99%
S&P+16.75%+83.6%+12.92%+48%
Advertisement

Cardio Diagnostics Company Info

Cardio Diagnostics Holdings, Inc. engages in the provision of medical diagnostic testing services. It also develops and commercializes a series of products for major types of cardiovascular disease and associated co-morbidities including coronary heart disease (CHD), stroke, heart failure, and diabetes. The company was founded in 2007, and is headquartered in Chicago, IL.

News & Analysis

No results found

No news articles found for Cardio Diagnostics.

Financial Health

General

Q3 2025YOY Change
Revenue$2.86K-56.6%
Gross Profit-$86.73K-14.2%
Gross Margin-3037.93%-1883.9%
Market Cap$7.07M4.5%
Market Cap / Employee$543.86K0.0%
Employees130.0%
Net Income-$1,714.54K-21.4%
EBITDA-$1,622.01K-22.3%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q3 2025YOY Change
Net Cash$6.36M220.6%
Accounts Receivable$11.22K-20.4%
Inventory00.0%

Liabilities

Q3 2025YOY Change
Long Term Debt$238.88K-50.9%
Short Term Debt$247.71K5.9%

Ratios

Q3 2025YOY Change
Return On Assets-98.75%59.3%
Return On Invested Capital-120.43%12.2%

Cash Flow

Q3 2025YOY Change
Free Cash Flow-$1,556.25K-31.8%
Operating Free Cash Flow-$1,393.42K-20.4%

Valuation

MetricQ4 2024Q1 2025Q2 2025Q3 2025YoY Change
Price to Book4.411.510.550.72-60.90%
Price to Sales1207.53838.76320.94446.66192.44%
Price to Tangible Book Value275.8551.390.590.77-98.78%
Enterprise Value to EBITDA-24.63-5.180.68-0.73-76.95%
Return on Equity-134.0%-81.2%-97.7%-110.7%-59.94%
Total Debt$969.86K$796.82K$623.12K$486.60K-32.46%

No results found

No podcast episodes available.

No results found

No transcripts available.

Advertisement

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.